News

Spot Sign Predicts Intracerebral Hemorrhage Growth

Publish date: March 7, 2011

 

FROM THE INTERNATIONAL STROKE CONFERENCE

The study was funded by the Canadian Stroke Consortium and by Novo Nordisk, which is developing rFVIIa. Dr. Demchuk did not receive any personal financial support from Novo Nordisk.

Pages

Recommended Reading

Video Report: Traumatic Brain Injury as a Chronic Condition
MDedge Internal Medicine
FDA Says No to Oral Multiple Sclerosis Drug
MDedge Internal Medicine
Carotid Bypass Offers No Benefit in Preventing Secondary Stroke
MDedge Internal Medicine
New Dietary Factors Associated With Greater Risk for Stroke
MDedge Internal Medicine
Extreme BMI Associated With Deep Intracerebral Hemorrhage
MDedge Internal Medicine
Registry Supports MERCI Trials Data, but Methods Criticized
MDedge Internal Medicine
Rule Can Predict Walking Outcomes After Spinal Cord Injury
MDedge Internal Medicine
Data Link High Oral Cleft Risk to Topiramate
MDedge Internal Medicine
Prophylactic Levetiracetam Fails to Reduce Post-TBI Seizures
MDedge Internal Medicine
Doubt Cast on Major Role for PFO Closure in Cryptogenic Stroke
MDedge Internal Medicine

Related Articles